Hey there 👋 Welcome to The Buzz – the fertility industry newsletter for the people experiencing it, running it and trying to make it work better. Five minutes. Let's get into it.

📋 IN THIS ISSUE

  • 🔬 A device just found viable eggs in fluid clinics throw away

  • 💡 What Ontario’s new pay transparency law actually means for your staff

  • 🐝 Kindbody’s rebrand, UNC’s partnership and a molecular switch for sperm

  • 📊 A stat that connects fertility to something bigger

🔬RESEARCH

A new device is finding extra eggs in fluid clinics throw away.

Every egg retrieval ends the same way. An embryologist searches through follicular fluid under a microscope, finds what they can and discards the rest. The fluid is messy – blood, clots, tissue – and everyone assumes what's left isn't worth saving.

Bad assumption. And inefficient, it seems.

A study published this month in Nature Medicine tested a microfluidic device called FIND-Chip that filters through that discarded fluid automatically. Messy fluid goes in, the device separates eggs from everything else through a series of microchannels and clean isolated eggs come out the other end. Across four clinics, it found usable eggs in fluid that had already been searched and discarded in 54.3% of cases. One of those recovered eggs led to a healthy baby that would have otherwise never existed. (Emphasis ours!)

It takes about 30 minutes. It doesn't require a trained embryologist to run. And even when embryologists were given unlimited time to double-check, the chip still found eggs they missed.

So what: IVF is expensive and emotional. Even one or two extra eggs could change the outcome for a family. The device isn't available for purchase yet, but this proof of concept is getting us excited enough to follow this story.

Bottom line: Not every breakthrough needs to be an AI announcement. Sometimes it's a chip that checks the bin - and could result in new life.

💡FROM THE HIVE

Ontario just made your salary ranges public. Here's what that costs you if you get it wrong.

As of January 1, Ontario employers with 25 or more employees have to post salary ranges on every public job listing. The range can't be wider than $50,000. That covers most fertility clinics in the province.

Three things clinic operators should know:

1. Pay is no longer a black box. Candidates can comparison shop. Clinics that pay competitively can use this as a recruiting advantage. Clinics that don't are about to find out what a competitive market it can be.

2. You have to disclose if you're using AI in hiring. Even basic ATS resume filtering may require a disclosure statement.

3. You can't require "Canadian experience" anymore. Clinics struggling to hire embryologists and nurses just got access to a wider talent pool.

You also have to notify interviewed candidates within 45 days and keep all postings on file for three years.

Now here's the number that should make this urgent. Replacing a clinical staff member in Canada costs an estimated 1.5 to 2x their annual salary - roughly $75-84k for a nurse or senior coordinator, according to a recent healthcare turnover white paper. Salary transparency won't fix staff turnover. But now that candidates can see what you're paying, getting it wrong just got a lot more expensive.

🐝 THE BUZZ BOARD

🤝 UNC Fertility is partnering with IVI RMA North America - the global network that includes Toronto's TRIO. Another PE-backed group absorbing an academic fertility program. We're tracking the pattern (Ask Hudson's Bay how that went.)

🏥 VC-backed Kindbody (American fertility co.) launched a "next-generation fertility platform" that mentions AI roughly once per paragraph. Underneath the buzzwords: national clinic partnerships, a medication portal and a pregnancy app covering 3 million lives by 2027.

🧬 A wrist-worn device that estimates estrogen, progesterone, LH and FSH in real time ships in November. No blood draws, no urine strips - just 10 biosensors and a design that hopefully matches your Oura ring. (Thanks to reader Thaise for the tip.)

🔬 Researchers found the molecular "switch" that powers sperm. A Michigan State team identified an enzyme called aldolase - early-stage, but it could open doors for both male infertility treatment and nonhormonal contraception.

📊 THE COUNT

30%

The reduction in ovarian cancer risk associated with having two or more children, according to a large South Korean study.

Have a story tip, a strong opinion or a question you want us to dig into? Hit reply – we read everything.

If someone forwarded this to you, subscribe here so you don't miss next Friday.

– Violet @ The Buzz 🐝

Keep Reading